Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | - CHEMBL12193
- delta-valerolactam
- piperidin-2-one
|
BDBM100101
| 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | - Cathepsin B
- Cathepsin H
- Kallikrein 7
| - 2-(4-Bromo-phenyl)-2,3-dihydro-1H-quinazolin-4-one
- 2-(4-bromophenyl)-2,3-dihydro-1H-quinazolin-4-one
- MLS001212491
- SMR000515221
- cid_3117357
|
BDBM100205
| 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | - Alpha trans-inducing protein (VP16)
- COUP transcription factor 2 isoform a
- Cystic fibrosis transmembrane conductance regulator
| - MLS000561583
- N-[5-[2-(5-chloro-2-methoxy-anilino)thiazol-4-yl]-4-methyl-thiazol-2-yl]-2,2-dimethyl-propionamide
- N-[5-[2-(5-chloro-2-methoxyanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethylpropanamide
- N-[5-[2-(5-chloro-2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2,2-dimethylpropanamide
- N-[5-[2-[(5-chloranyl-2-methoxy-phenyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethyl-propanamide
- SMR000156108
- cid_11958611
|
BDBM10024
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 5-(1H-imidazol-1-ylmethyl)-5,6,7,8-tetrahydroquinoline
- 5-[(Imidazol-1-yl)methyl]-5,6,7,8-tetrahydroquinoline
- tetrahydroquinoline 45
|
BDBM10028
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 5-[2-(1H-imidazol-1-yl)ethyl]quinoline
- 5-[2-(Imidazol-1-yl)ethyl]quinoline
- CHEMBL54803
- quinoline 33
|
BDBM10031
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 5-[3-(1H-imidazol-1-yl)propyl]-7,8-dihydroquinoline
- 5-[3-(Imidazol-1-yl)propyl]-7,8-dihydroquinoline
- CHEMBL53290
- dihydroquinoline 50
|
BDBM10035
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 1-[(2Z)-2-(6,7-dihydro-1-benzofuran-4(5H)-ylidene)ethyl]-1H-imidazole
- 1-{2-[(4Z)-4,5,6,7-tetrahydro-1-benzofuran-4-ylidene]ethyl}-1H-imidazole
- CHEMBL56059
- Tetrahydrobenzo[b]furan 34Z
|
BDBM10036
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 1-[(2E)-2-(6,7-dihydro-1-benzothien-4(5H)-ylidene)ethyl]-1H-imidazole
- 1-{2-[(4E)-4,5,6,7-tetrahydro-1-benzothiophen-4-ylidene]ethyl}-1H-imidazole
- CHEMBL57513
- Tetrahydrobenzo[b]thiophene 35E
|
BDBM100363
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Epoxide hydratase
- Epoxide hydrolase 1
- Soluble epoxide hydrolase (sEH)
| - US8501783, 1163
- US9296693, 2
|
BDBM10037
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 1-[(2Z)-2-(6,7-dihydro-1-benzothien-4(5H)-ylidene)ethyl]-1H-imidazole
- 1-{2-[(4Z)-4,5,6,7-tetrahydro-1-benzothiophen-4-ylidene]ethyl}-1H-imidazole
- CHEMBL55558
- tetrahydrobenzo[b]thiophene 35Z
|
BDBM10038
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Aromatase (CYP19)
- Thromboxane A2 Synthase (P450 TxA2)
| - 1-[2-(1-benzothiophen-4-yl)ethyl]-1H-imidazole
- 1-[2-(Benzo[b]thiophen-4-yl)ethyl]-1H-imidazole
- Benzo[b]thiophene 32
- CHEMBL460382
|
BDBM10042
| 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Prostaglandin transporter (PGT)
- TBXA2R
| - (5Z)-7-[(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid
- (5Z,13E,15S)-9alpha, 11alpha-epidioxy-15-hydroxyprosta-5,13-dienoic acid
- 9,11-epoxymethano PGH2
- PGH2
- Prostaglandin H2
|
BDBM10044
| 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | - (2S,15S)-15-methyl-2-[(methylsulfanyl)methyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione
- CHEMBL101540
- RU54115 Analog 57
|
BDBM100714
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Hepatocyte growth factor receptor
- Phosphodiesterase 3
| - US8507676, 63
- US9062045, Comparator No. 2
|
BDBM100876
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100877
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100878
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100879
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100880
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100882
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100883
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100884
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100885
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100886
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100887
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100890
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100892
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100893
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100894
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100895
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100896
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100897
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100898
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100899
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100900
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100901
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100902
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100903
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100904
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100907
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100908
| 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2)
| |
BDBM100909
| 0 | 3 | 0 | 0 | 0 | 0 |